Australian Clinical Labs Future Growth
Future criteria checks 4/6
Australian Clinical Labs is forecast to grow earnings and revenue by 24.4% and 4.5% per annum respectively. EPS is expected to grow by 26% per annum. Return on equity is forecast to be 21.6% in 3 years.
Key information
24.4%
Earnings growth rate
26.0%
EPS growth rate
| Healthcare earnings growth | 19.9% |
| Revenue growth rate | 4.5% |
| Future return on equity | 21.6% |
| Analyst coverage | Good |
| Last updated | 20 Mar 2024 |
Recent future growth updates
Recent updates
Are Investors Undervaluing Australian Clinical Labs Limited (ASX:ACL) By 46%?
Feb 21
Is It Time To Consider Buying Australian Clinical Labs Limited (ASX:ACL)?
Dec 08Here's Why We Think Australian Clinical Labs (ASX:ACL) Might Deserve Your Attention Today
Aug 14Australian Clinical Labs Limited (ASX:ACL) Just Reported Half-Year Earnings: Have Analysts Changed Their Mind On The Stock?
Feb 25New Forecasts: Here's What Analysts Think The Future Holds For Australian Clinical Labs Limited (ASX:ACL)
Dec 22The Market Lifts Australian Clinical Labs Limited (ASX:ACL) Shares 31% But It Can Do More
Dec 21The Strong Earnings Posted By Australian Clinical Labs (ASX:ACL) Are A Good Indication Of The Strength Of The Business
Sep 01Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 6/30/2026 | 747 | 44 | 48 | 172 | 7 |
| 6/30/2025 | 711 | 39 | 46 | 165 | 8 |
| 6/30/2024 | 683 | 29 | 36 | 150 | 8 |
| 12/31/2023 | 674 | 15 | 147 | 154 | N/A |
| 9/30/2023 | 686 | 26 | 142 | 149 | N/A |
| 6/30/2023 | 697 | 36 | 137 | 144 | N/A |
| 3/31/2023 | 757 | 55 | 143 | 154 | N/A |
| 12/31/2022 | 818 | 73 | 148 | 165 | N/A |
| 9/30/2022 | 907 | 126 | 206 | 225 | N/A |
| 6/30/2022 | 996 | 178 | 263 | 284 | N/A |
| 3/31/2022 | 931 | 156 | 238 | 256 | N/A |
| 12/31/2021 | 867 | 134 | 214 | 228 | N/A |
| 9/30/2021 | 757 | 97 | 179 | 191 | N/A |
| 6/30/2021 | 647 | 60 | 144 | 154 | N/A |
| 3/31/2021 | 598 | 79 | N/A | N/A | N/A |
| 12/31/2020 | 549 | 98 | N/A | N/A | N/A |
| 9/30/2020 | 520 | 70 | N/A | N/A | N/A |
| 6/30/2020 | 491 | 41 | 92 | 102 | N/A |
| 6/30/2019 | 448 | -11 | -13 | 1 | N/A |
| 6/30/2018 | 379 | -9 | -4 | 5 | N/A |
| 6/30/2017 | 340 | -24 | N/A | 5 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ACL's forecast earnings growth (24.4% per year) is above the savings rate (2.2%).
Earnings vs Market: ACL's earnings (24.4% per year) are forecast to grow faster than the Australian market (13.4% per year).
High Growth Earnings: ACL's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: ACL's revenue (4.5% per year) is forecast to grow slower than the Australian market (4.7% per year).
High Growth Revenue: ACL's revenue (4.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ACL's Return on Equity is forecast to be high in 3 years time (21.6%)